Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design
Jon B. Toledo, Carla Abdelnour, Rimona S. Weil, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 1, pp. 318-332
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Clinical effects of Lewy body pathology in cognitively impaired individuals
Corinne Quadalti, Sebastian Palmqvist, Sara Hall, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1964-1970
Open Access | Times Cited: 76
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
Giovanni B. Frisoni, Cristina Festari, Federico Massa, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 3, pp. 302-312
Open Access | Times Cited: 47
Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta‐analysis
Paul C. Donaghy, Claudia Carrarini, Daniel Ferreira, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 7, pp. 3186-3202
Open Access | Times Cited: 27
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
Lucy L. Gibson, Carla Abdelnour, Joyce R. Chong, et al.
Current Opinion in Neurology (2023)
Open Access | Times Cited: 23
Neuropsychological test performance in mild cognitive impairment with Lewy bodies: A systematic review and meta‐analysis
Kathryn A. Wyman‐Chick, Ece Bayram, Stephanie Gravett, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 1
Fluid and Biopsy Based Biomarkers in Parkinson's Disease
David G. Coughlin, David J. Irwin
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 932-954
Open Access | Times Cited: 21
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 7
Lewy body dementia: Overcoming barriers and identifying solutions
Kanishka Agarwal, Wendi Backler, Ece Bayram, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 3, pp. 2298-2308
Open Access | Times Cited: 6
Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
Carla Abdelnour, Maria Camila González, Lucy L. Gibson, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 3, pp. 727-749
Open Access | Times Cited: 15
Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis
Carmen Peña‐Bautista, Rakesh Kumar, Miguel Baquero, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 15
Movement Disorders Society Viewpoint on Biological Frameworks of Parkinson's Disease: Current Status and Future Directions
Lorraine V. Kalia, Daniela Berg, Jeffery H. Kordower, et al.
Movement Disorders (2024) Vol. 39, Iss. 10, pp. 1710-1715
Open Access | Times Cited: 5
Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions
Deirdre O’Shea, Alexander Arkhipenko, Douglas Galasko, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 4
Managing cognitive impairment in Parkinson’s disease: an update of the literature
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access
Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum
Daniel Ferreira, Scott A. Przybelski, Timothy G. Lesnick, et al.
JAMA Neurology (2025)
Closed Access
Neuropsychological and clinical indicators of Lewy body and Alzheimer's pathology
Abigail Simpson, Kathryn A. Wyman‐Chick, Michael S Daniel
Journal of Alzheimer s Disease Reports (2025) Vol. 9
Open Access
Parkinsonism in Alzheimer's disease without Lewy bodies in association with nigral neuron loss: A data‐driven clinicopathologic study
Daisuke Ono, Hiroaki Sekiya, Andreas Maier, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
MRI-specific signature of dementia with Lewy bodies—a step towards improved differential diagnosis of the dementia spectrum
Maria Marcella Laganà, Dejan Jakimovski
European Radiology (2025)
Closed Access
Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies
Paul C. Donaghy, Jahfer Hasoon, Calum A. Hamilton, et al.
Movement Disorders (2025)
Open Access
In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use
Juan I. López-Carbonero, Irene García-Toledo, Laura Fernández-Hernández, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia
K. A. Jellinger
Journal of Neural Transmission (2023) Vol. 130, Iss. 7, pp. 891-904
Closed Access | Times Cited: 9
Concerns with the new biological research criteria for synucleinopathy
Jennifer G. Goldman, Bradley F Boeve, Doug Galasko, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 7, pp. 660-661
Closed Access | Times Cited: 3
Advanced qEEG analyses discriminate between dementia subtypes
Masha Burelo, Jack Bray, Olga Gulka, et al.
Journal of Neuroscience Methods (2024) Vol. 409, pp. 110195-110195
Open Access | Times Cited: 3
Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease
Carla Abdelnour, Christina B. Young, Marian Shahid, et al.
Annals of Neurology (2024) Vol. 96, Iss. 3, pp. 526-538
Open Access | Times Cited: 3
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks
K. A. Jellinger
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 498-498
Open Access | Times Cited: 8
Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy
Zhibo Wang, Lan Tan, Hui‐Fu Wang, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 8, pp. 3613-3624
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top